1
Views
31
CrossRef citations to date
0
Altmetric
Transcriptional Regulation

The Retinoblastoma Gene Product RB Stimulates Spl-Mediated Transcription by Liberating Spl from a Negative Regulator

, , , , , , & show all
Pages 4380-4389 | Received 11 Aug 1993, Accepted 13 Apr 1994, Published online: 30 Mar 2023

Refrences

  • Angel, P., I. Baumann, B. Stein, H. Delius, H. J. Rahmsdorf, and P. Herrlich. 1987. 12-0-Tetradecanoyl-phorbol-13-acetate induction of the human collagenase gene is mediated by an inducible enhancer element located in the 5′ flanking region. Mol. Cell. Biol. 7: 2256–2266.
  • Angel, P., M. Imagawa, R. Chiu, B. Stein, R. J. Imbra, H. J. Rahmsdorf, C. Jonat, P. Herrlich, and M. Karin. 1987. Phorbol ester-inducible genes contain a common cis-element recognized by TPA-modulated trans-acting factor. Cell 49: 729–739.
  • Bagchi, S., R. Weinmann, and P. Raychaudhuri. 1991. The retinoblastoma protein copurifies with E2F-I, an ElA-regulated inhibitor of the transcription factor E2F. Cell 65: 1063–1072.
  • Bernards, R., G. M. Schackleford, M. R. Gerber, J. M. Horowitz, S. H. Friend, M. Schartl, E. Bogenmann, J. M. Rapaport, T. McGee, T. P. Dryja, and R. A. Weinberg. 1989. Structure and expression of the murine retinoblastoma gene and characterization of its encoded protein. Proc. Natl. Acad. Sci. USA 86: 6474–6478.
  • Bookstein, R., P. Rio, S. A. Madreperia, F. Hong, C. Allred, W. R. Grizzle, and W.-H. Lee. 1990. Promoter deletion and loss of retinoblastoma gene expression in human prostate carcinoma. Proc. Natl. Acad. Sci. USA 87: 7762–7766.
  • Brenner, D. A., M. O'Hara, P. Angel, M. Chojkier, and M. Karin. 1989. Prolong activation of jun and collagenase genes by tumour necrosis factor-α. Nature (London) 337: 661–663.
  • Buchkovich, K., L. A. Duffy, and E. Harlow. 1989. The retinoblastoma protein is phosphorylated during specific phases of cell cycle. Cell 58: 1097–1105.
  • Chellappan, S. P., S. Hiebert, M. Mudryj, J. M. Horowitz, and J. R. Nevins. 1991. The E2F transcription factor is a cellular target for the RB protein. Cell 65: 1053–1061.
  • Chen, P.-L., Y. Chen, B. Shan, R. Bookstein, and W.-H. Lee. 1992. Stability of RB expression determines the tumorigenicity of reconstituted retinoblastoma cells. Cell Growth Differ. 3: 119–125.
  • Chen, P.-L., P. Scully, J.-Y. Shew, J. Y. J. Wang, and W.-H. Lee. 1989. Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation. Cell 58: 1193–1198.
  • Chiu, R., W. J. Boyle, J. Meek, T. Smeal, T. Hunter, and M. Karin. 1988. The c-Fos protein interacts with c-Jun/AP-1 to stimulate transcription of AP-1 responsive genes. Cell 54: 541–552.
  • Courey, A. J., and R. Tjian. 1988. Analysis of Spl in vivo reveals multiple transcriptional domains, including a novel glutamine-rich activation motif. Cell 55: 887–898.
  • Coussens, L., and R. Chiu. Unpublished data.
  • DeCaprio, J. A, J. W. Ludlow, D. Lynch, Y. Furukawa, J. Griffin, H. Piwnica-Worms, C.-M. Huang, and D. M. Livingston. 1989. The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element. Cell 58: 1085–1095.
  • Emami, K. H., and M. Carey. 1992. A synergistic increase in potency of a multimerized VP 16 transcriptional activation domain. EMBO J. 11: 5005–5012.
  • Friend, S. H., R. Bernards, S. Rogelj, R. A. Weinberg, J. M. Rapaport, D. M. Albert, and T. P. Dryja. 1986. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature (London) 323: 643–646.
  • Gorman, C. M., L. F. Moffat, and B. H. Howard. 1982. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol. Cell. Biol. 2: 1044–1051.
  • Harbour, J. W., S.-L. Lai, J. Whang-Peng, A. F. Gazdar, J. D. Minna, and F. J. Kaye. 1988. Abnormalities in structure and expression of the human retinoblastoma gene in SCLC. Science 241: 353–357.
  • Huang, H.-J. S., J.-K. Yee, J.-Y. Shew, P.-L. Chen, R. Bookstein, T. Friedmann, E. Y.-H. P. Lee, and W.-H. Lee. 1988. Suppression of the neoplastic phenotype by replacement of the retinoblastoma gene product in human cancer cells. Science 242: 1563–1566.
  • Jackson, S. P., J. J. MacDonald, M. S. Lees, and R. Tjian. 1990. GC box binding induces phosphorylation of Spl by a DNA-kinase. Cell 63: 155–165.
  • Kim, S.-J., H.-D. Lee, P. D. Robbins, K. Busam, M. B. Sporn, and A. B. Roberts. 1991. Regulation of transforming growth factor βl gene expression by the product of the retinoblastoma susceptibility gene. Proc. Natl. Acad. Sci. USA 88: 3052–3056.
  • Kim, S.-J., U. S. Onwuta, Y. I. Lee, R. Li, M. R. Botchan, and P. D. Robbins. 1992. The retinoblastoma gene product regulates Spl-mediated transcription. Mol. Cell. Biol. 12: 2455–2463.
  • Kim, S.-J., S. Wagner, F. Liu, M. A. O'Reilley, P. D. Robbins, and M. R. Green. 1992. Retinoblastoma gene product activates expression of the human TGF-β2 gene through transcription factor ATF-2. Nature (London) 358: 331–334.
  • Kingsley, C., and A. Winoto. 1992. Cloning of GT box-binding proteins: a novel Spl multigene family regulating T-cell receptor gene expression. Mol. Cell. Biol. 12: 4251–4261.
  • Kitabayashi, I., R. Chiu, G. Gachelin, and K. Yokoyama. 1991. E1A dependent up-regulation of c-jun/AP-1 activity. Nucleic Acids Res. 19: 649–655.
  • Kitabayashi, I., Z. Kawakami, R. Chiu, K. Ozawa, T. Matsuoka, S. Toyoshima, K. Umesono, R. M. Evans, G. Gachelin, and K. Yokoyama. 1992. Transcriptional regulation of the c-jun gene by retinoic acid and E1A during differentiation of F9 cells. EMBO J. 11: 167–175.
  • Lamph, W. W., P. Wamsley, P. Sassone-Corsi, and I. M. Verma. 1988. Induction of proto-oncogene Jun/AP-1 by serum and TP A Nature (London) 334: 629–631.
  • Li, R., J. D. Knight, S. P. Jackson, R. Tjian, and M. Botchan. 1991. Direct interaction between Spl and BPV enhancer E2 protein mediates synergistic activation of transcription. Cell 65: 493–505.
  • Lin, B. T., S. Gruenwald, A. O. Morla, W.-H. Lee, and J. Y. Wang. 1991. Retinoblastoma cancer suppressor gene product is a substrate of the cell cycle regulator cdc2 kinase. EMBO J. 10: 857–864.
  • Ludlow, J. W., J. Shon, J. M. Pipas, D. M. Livingston, and J. A. DeCaprio. 1990. The retinoblastoma susceptibility gene product undergoes cell cycle-dependent dephosphorylation and binding to and release form SV 40 large T. Cell 60: 387–396.
  • Muegge, K., T. M. Williams, J. Kant, R. Chiu, M. Karin, A. Schmidt, H. A. Young, and S. K. Durum. 1989. Interleukin 1 costimulatory activity on the interleukin 2 promoter via AP-1. Science 246: 249–251.
  • Pietenpol, J. A., K. Münger, P. M. Howley, R. W. Stein, and H. L. Moses. 1991. Factor-binding element in the human c-myc promoter involved in transcriptional regulation by transforming growth factor βl and by the retinoblastoma gene product. Proc. Natl. Acad. Sci. USA 88: 10227–10231.
  • Rauscher, F. J., L. C. Sambucetti, T. Curran, R. J. Distel, andB. M. Spiegelman. 1988. A common DNA binding site for Fos protein complexes and transcription factor AP-1. Cell 52: 471–480.
  • Robbins, P. D., J. M. Horowitz, and R. C. Mulligan. 1990. Negative regulation of human c-fos expression by the retinoblastoma gene product. Nature (London) 346: 668–671.
  • Ryder, K., and D. Nathans. 1988. Induction of protooncogene c-jun by serum growth factors. Proc. Natl. Acad. Sci. USA 85: 8464–8467.
  • Ryseck, R.-P., S. Hirai, M. Yaniv, and R. Bravo. 1988. Transcriptional activation of c-jun during the G0/G1 transition in mouse fibroblasts. Nature (London) 334: 535–537.
  • Sadowski, I., J. Ma, S. Triezenberg, and M. Ptashne. 1988. Gal4-VP16 is an unusually potent transcriptional activator. Nature (London) 335: 563–564.
  • Sadowski, I., and M. Ptashne. 1989. A vector for expressing GAL4( 1-147) fusions in mammalian cells. Nucleic Acids Res. 17: 7539.
  • Saffer, J. D., S. P. Jackson, and S. J. Thurston. 1990. SV40 stimulates expression of the transacting factor Spl at the mRNA level. Genes Dev. 4: 659–666.
  • Sakai, T., N. Ohtani, T. L. McGee, P. D. Robbins, and T. P. Dryja. 1991. Oncogenic germ-line mutations in Spl and ATF sites in the human retinoblastoma gene. Nature (London) 353: 83–86.
  • Sanger, F., S. Nicklen, and A. R. Coulson. 1977. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 74: 5463–5467.
  • Schütte, J., J. D. Minna, and M. Birrer. 1989. Deregulated expression of human c-jun transforms primary rat embryo cells in cooperation with an activated c-Ha-ras gene and transforms Rat-la cells as a single gene. Proc. Natl. Acad. Sci. USA 86: 2257–2261.
  • Schütte, J., J. Viallet, M. Nau, S. Segal, J. Federko, and J. Minna. 1989. junB inhibits and c-fos stimulates the transforming and transactivating activities of c-jun. Cell 59: 987–997.
  • T'Ang, A., J. M. Varley, S. Chakraborty, A. L. Murphree, and Y.-K. T. Fung. 1988. Structural rearrangement of the retinoblastoma gene in human breast carcinoma. Science 242: 263–266.
  • Toguchida, J., K. Ishizaki, M. S. Sasaki, M. Ikenaga, M. Sugimoto, Y. Kotoura, and T. Yamamuro. 1988. Chromosomal reorganization for the expression of recessive mutation of retinoblastoma susceptibility gene in the development of osteosarcoma. Cancer Res. 48: 3939–3943.
  • Udvadia, A. J., K. T. Rogers, P. D. R. Higgins, Y. Murata, K. H. Martin, P. A. Humphrey, and J. M. Horowitz. 1993. Spl binds promoter elements regulated by the RB protein and Spl-mediated transcription is stimulated by RB coexpression. Proc. Natl. Acad. Sci. USA 90: 3265–3269.
  • Udvadia, A. J., K. T. Rogers, and J. M. Horowitz. 1992. A common set of nuclear factors bind to promoter elements regulated by the retinoblastoma protein. Cell Growth Differ. 3: 597–608.
  • Wang, C.-Y., B. Petryniak, C. B. Thompson, W. G. Kaelin, and J. M. Leiden. 1993. Regulation of the Ets-related transcription factor Elf-1 by binding to the retinoblastoma protein. Science 260: 1330–1335.
  • Weichselbaum, R. R., M. Beckett, and A. Diamond. 1988. Some retinoblastomas, osteosarcomas, and soft-tissue sarcomas may share a common etiology. Proc. Natl. Acad. Sci. USA 85: 2106–2109.
  • Yokota, J., T. Akiyama, Y.-K. T. Fung, W. F. Benedict, Y. Namba, M. Hanaoka, M. Wada, T. Terasaki, Y. Shimosato, T. Sugimura, and M. Terada. 1988. Altered expression of the retinoblastoma (RB) gene in small-cell carcinoma of the lung. Oncogene 3: 471–475.
  • Yu, D., A. Matin, and M.-C. Hung. 1992. The retinoblastoma gene product suppress neu oncogene-induced transformation via transcriptional repression of neu. J. Biol. Chem. 267: 10203–10206.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.